Aortic Valve Replacement in the Current Era

Shannon Parness1, Jack T Womble1, Tori E Hester1

  • 1Division of Cardiothoracic Surgery, Department of Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

PubMed

Insights

Aortic valve replacement (AVR) treats severe aortic valve disease (AVD). New techniques like TAVR expand treatment options, improving outcomes for more patients with AVD.

Area of Science:

  • Cardiovascular Surgery
  • Valvular Heart Disease
  • Medical Technology

Background:

  • Aortic valve disease (AVD) is a widespread global health issue.
  • Aortic valve replacement (AVR) is the primary surgical intervention for severe AVD.
  • AVD stems from various causes, including aortic stenosis, aortic insufficiency, endocarditis, and congenital defects.

Purpose of the Study:

  • To review the current landscape of aortic valve replacement (AVR) for aortic valve disease (AVD).
  • To highlight advancements in surgical techniques and their impact on patient candidacy.
  • To emphasize the importance of personalized treatment strategies in AVR.

Main Methods:

  • Review of current literature on AVD and AVR.
  • Analysis of novel surgical techniques such as transcatheter AVR (TAVR) and sutureless valves.
  • Discussion of factors influencing AVR decision-making, including patient age and VKA compatibility.

Main Results:

  • AVR remains a cornerstone treatment for severe AVD.
  • Innovative techniques like TAVR and sutureless valves have broadened access to AVR.
  • Shared decision-making is crucial for selecting appropriate valve types and surgical approaches.

Conclusions:

  • Continued research is vital for enhancing patient outcomes and expanding AVR eligibility.
  • AVR is expected to maintain its significant role in managing AVD.
  • Personalized patient care, considering age and VKA compatibility, is key to successful AVR outcomes.